Abstract
Introduction. Ovarian tissue cryopreservation is an important method for fertility preservation in pre- and pubertal patients. It offers several advantages, including the avoidance of ovulation stimulation and no delay in initiating chemotherapy. Recent advancements in laparoscopic harvesting, storage, and autotransplantation of ovarian cortex tissue have resulted in an estimated live birth rate of 35–40% in adult cancer patients. Although considered experimental until 2019, the technique has since led to the birth of over 200 children worldwide, solidifying its position as one of the primary fertility preservation methods. Currently, laparoscopic ovarian tissue retrieval, slow-freeze cryopreservation before specialized treatment, and post-recovery autotransplantation of ovarian (cortical) tissue may represent the gold standard for fertility preservation in prepubertal girls. However, Russia has yet to establish a standardized implementation protocol, including selection criteria, patient recruitment guidelines, and legal support for children and their parents (or guardians). Also, the country lacks a centralized cryobank for storing biological material.
Materials and Methods. The clinical study protocol was initiated at the N.N.Petrov National Medical Research Center of Oncology (Ministry of Health of Russia) and approved by the Local Ethics Committee (Protocol No. 16, dated 21.03.2023). This single-center, randomized study investigates fertility preservation methods in pre- and pubertal girls with cancer. Out of 120 screened patients, 50 were randomized for participation. The study population consists of girls under 18 years of age diagnosed with cancer.
Conclusion. Several effective yet still experimental methods exist for fertility preservation in children. For girls facing highly gonadotoxic antitumor therapy, ovarian tissue cryopreservation may be considered before treatment. This involves surgically removing and freezing ovarian tissue for future reimplantation after recovery. This method has disadvantages because it is invasive and requires general anesthesia, as well as advantages, as it can be performed as early as one year of age. An alternative approach, feasible one year after puberty, involves ovarian stimulation followed by follicular puncture for oocyte cryopreservation. While less invasive, this method offers more limited reproductive potential compared to ovarian tissue preservation.
Further studies are essential to evaluate the relevance and efficacy of these techniques, ensuring optimal fertility preservation strategies for pediatric patients.
References
Колыгин Б.А. Последствия противоопухолевой терапии у детей. Б.А. Колыгин, С.А. Кулева. СПб.: Гиппократ. 2011; 184. [Kolygin B.A. Consequences of antitumor therapy in children. B.A. Kolygin, S.A. Kuleva. St. Petersburg: Gipppokrat. 2011; 184 (In Rus)].
Farland L.V., Stern J.E., Hwang S.S., et al. History of cancer and fertility treatment outcomes: a registry linkage study in Massachusetts. J Assist Reprod Genet. 2022; 39(2): 517-526.-DOI: 10.1007/s10815-021-02376-x.
Cherven B., Quast L.F., James L., et al. Contraceptive methods and fertility testing in young adult survivors of childhood cancer. J Assist Reprod Genet. 2023; 40(10): 2391–2400.-DOI: 10.1007/s10815-023-02908-7.
Tucci C.D., Galati G., Mattei G., et al. Fertility after cancer: risks and successes. Cancers (Basel). 2022; 14 (10): 2500.-DOI: 10.3390/раки14102500.
Rodriguez-Wallberg K.A., Jiang Y., Lekberg T., et al. The late effects of cancer treatment on female fertility and the current status of fertility preservation — a narrative review. Life (Basel). 2023; 13(5): 1195.-DOI: 10.3390/жизнь13051195.
Chen L., Dong Z., Chen X. Fertility preservation in pediatric healthcare: a review. Front Endocrinol (Lausanne). 2023; 14: 1147898.-DOI: 10.3389/fendo.2023.1147898.
Halpern J.A., Das A., Faw C.A., et al. Oncofertility in adult and pediatric populations: options and barriers. Transl Androl Urol. 2020; 9(2): 227–238.-DOI: 10.21037/tau.2019.09.27.
Plancha C.E., Kovačič B. From glass to life: a commentary on the assessment of the reproductive potential of cryopreserved human oocytes. J Assist Reprod Genet. 2022; 39(9): 1993–1996.-DOI: 10.1007/s10815-022-02565-2.
Liang T., Motan T. Mature oocyte cryopreservation for fertility preservation. Adv Exp Med Biol. 2016; 951: 155-161.-DOI: 10.1007/978-3-319-45457-3_13.
Albamonte M.I., Albamonte M.S., Bou-Khair R.M., et al. The ovarian germinal reserve and apoptosis-related proteins in the infant and adolescent human ovary. J Ovarian Res. 2019; 12: 22.
Jiang M., Gao Y., Qu T., Ji Y., et al. Dose inhibin B or anti-Müllerian hormone relate to precocious puberty in girls? result of a systematic review and meta-analysis. J Ovarian Res. 2023; 16: 227.-DOI: 10.1186/s13048-023-01302-2.
Busnelli A., Vitagliano A., Mensi L., et al. Fertility in female cancer survivors: a systematic review and meta-analysis. Reprod Biomed Online. 2020; 41(1); 96-112.-DOI: 10.1016/j.rbmo.2020.02.008.
Torella M., Riemma G., De Franciscis P., et al. Serum anti-müllerian hormone levels and risk of premature ovarian insufficiency in female childhood cancer survivors: systematic review and network meta-analysis. Cancers (Basel). 2021; 13(24): 6331.-DOI: 10.3390/cancers13246331.
Oktem O., Kim S.S., Selek U., et al. Ovarian and uterine functions in female survivors of childhood cancers. Oncologist. 2018; 23(2): 214–224.
Wallace W.H., Thomson A.B., Saran F., et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005; 3(62): 738–744.-DOI: 10.1016/j.ijrobp.2004.11.038.
Dijk M., Leeuwen F.E., Overbeek A., et al. Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors: results of the DCOG LATER-VEVO study. J Cancer Res Clin Oncol. 2020; 146(6): 1451–1462.
Wallace W.H., Shalet S.M., Crowne E.C. Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis. Clin Oncol. 1989; 2(1): 75–79.-DOI: 10.1016/s0936-6555(89)80039-1.
van Dorp W., Mulder R.L., Kremer L.C.M., et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from/ the international late effects of childhood cancer guideline harmonization group in collaboration with the pancaresurfup consortium. J Clin Oncol. 2016; 34(28): 3440–3450.
Arecco L., Ruelle T., Martelli V., et al. How to protect ovarian function before and during chemotherapy? J Clin Med. 2021; 10(18): 4192.-DOI: 10.3390/jcm10184192.
Lambertini M., Boni L., Michelotti A., et al. Final analysis of the PROMISE-GIM6 phase III trial assessing GnRH agonist use during chemotherapy as a strategy to preserve ovarian function in premenopausal patients with early breast cancer. J Clin Oncol. 2021; 39: 516.-DOI: 10.1200/jco.2021.39.15_suppl.516.
Matsumoto M., Shinohara O., Ishiguro H., et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child Educ Pract Ed. 1999; 5(80): 452–454.-DOI: 10.1136/adc.80.5.452.
Fernandez-Pineda I., Davidoff A.M., Lu L., et al. Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study. Pediatr. Blood Cancer. 2018; 65(9): e27232.
Martinez F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017; 108(3): 407–15.e11.-DOI: 10.1016/j.fertnstert.2017.05.024.
De Roo C., Tilleman K. In vitro maturation of oocytes retrieved from ovarian tissue: outcomes from current approaches and future perspectives. J Clin Med. 2021; 10(20): 4680.
Segers I., Bardhi E., Mateizel I., et al. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes. Human Reproduction. 2020; 35(9): 2026–2036.-DOI: 10.1093/humrep/deaa175.
Sirait B., Jusuf A.A., Wiweko B., et al. Potential use of immature oocyte to improve fertility preservation outcome: a narrative review. J Hum Reprod Sci. 2022; 15(1): 3-11.-DOI: 10.4103/jhrs.jhrs_112_21.
Klipstein S., Fallat M.E., Savelli S. Committee on bioethics; section on hematology/oncology; section on surgery. Fertility preservation for pediatric and adolescent patients with cancer: medical and ethical considerations. Pediatrics. 2020; 145(3): e20193994.-DOI: 10.1542/peds.2019-3994.
Patrinos D., Knoppers B.M., Laplante D.P., et al. Sharing and safeguarding pediatric data. Front Genet. 2022; 13: 872586.-DOI: 10.3389/fgene.2022.872586.
Lau L.Sh., Allingham C., Anazodo A., et al. The Australian New Zealand Consortium in children, adolescents, and young adults oncofertility action plan. 2024.-DOI: 10.1002/pbc.31041.
Wallace W.H., Smith A.G., Kelsey T.W., et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014; 15(10): 1129-36.-DOI: 10.1016/S1470-2045(14)70334-1.
Takae S., Furuta S., Iwahataa H., et al. Cryopreservation of paediatric ovarian tissue with an updated version of the Edinburgh criteria for appropriate patient selection. Reprod Biomed Online. 2022; 44(4): 667-676.-DOI: 10.1016/j.rbmo.2021.10.009.
Su H.I., Lacchetti Ch., Letourneau J., et al. Fertility preservation in people with cancer: ASCO Guideline Update. J Clin Oncol. 2025: 00: 1-28.-DOI: 10.1200/JCO-24-02782.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2025